<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Mon, 11 May 2026 11:55:32 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/gnpx/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Top Gainers for 2-14-20: $BTAI $CC $CGC $DGLY $FTSI $GNPX $IMGN $INO]]></title><description><![CDATA[$BTAI - BioXcel Therapeutics to Present at the 2020 BIO CEO & Investor Conference (2/7/2020): $CC - Chemours (CC) Earnings Beat, Revenues Miss Estimates in Q4: $CGC - Canopy Jumps 25% After Beating]]></description><link>http://direct.ecency.com/topgainers/@jktrades/top-gainers-for-2-14-20-usdbtai-usdcc-usdcgc-usddgly-usdftsi-usdgnpx-usdimgn-usdino</link><guid isPermaLink="true">http://direct.ecency.com/topgainers/@jktrades/top-gainers-for-2-14-20-usdbtai-usdcc-usdcgc-usddgly-usdftsi-usdgnpx-usdimgn-usdino</guid><category><![CDATA[topgainers]]></category><dc:creator><![CDATA[jktrades]]></dc:creator><pubDate>Fri, 14 Feb 2020 15:43:33 GMT</pubDate><enclosure url="https://images.ecency.com/p/9vWp6aU4y8kwSZ9Gw15LFL3aMdhmgmBBFMpDJregpdP328Q52dF3eVdK9qbQnFBFrCRnwoSLmDzwkhyS4sUzXeCWFaJsiVyg6ZGcD1sFpAwMFygsWdk3NmPfYu4mUV2PtkmY8GifszgvWeSXY?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Top Gainers for 2-11-20: $AIM $AMKR $BRN $GNPX $S]]></title><description><![CDATA[$AIM - AIM ImmunoTech Files Three Provisional Patent Applications Surrounding Ampligen® for Use Against the SARS-like Wuhan 2019 Novel Coronavirus: $AMKR - Amkor Technology Reports Financial Results for]]></description><link>http://direct.ecency.com/topgainers/@jktrades/top-gainers-for-2-11-20-usdaim-usdamkr-usdbrn-usdgnpx-usds</link><guid isPermaLink="true">http://direct.ecency.com/topgainers/@jktrades/top-gainers-for-2-11-20-usdaim-usdamkr-usdbrn-usdgnpx-usds</guid><category><![CDATA[topgainers]]></category><dc:creator><![CDATA[jktrades]]></dc:creator><pubDate>Tue, 11 Feb 2020 15:10:21 GMT</pubDate><enclosure url="https://images.ecency.com/p/9vWp6aU4y8kwSZ9Gw15LFL3aMdhmgmBBFMpDJregpdP328rmhWK8EMUP2xeqdFzpkc4mni2Sk4pbXxspUJtz2azY95zB2rwqYVsN7vvE3zJNDy8ebTJcBXApkphZcxSdTPTef3LthJJEeWBrn?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Top Gainers for 1-29-20: $ATIF $GNPX $HEPA $LEE]]></title><description><![CDATA[$ATIF - ATIF Holdings Limited Contributes 1.5 Million Protective Masks to Wuhan’s Fight Against Coronavirus: $GNPX - Independent Researchers Find Genprex’s TUSC2 May Be a Novel Target and Biomarker for]]></description><link>http://direct.ecency.com/topgainers/@jktrades/top-gainers-for-1-29-20-usdatif-usdgnpx-usdhepa-usdlee</link><guid isPermaLink="true">http://direct.ecency.com/topgainers/@jktrades/top-gainers-for-1-29-20-usdatif-usdgnpx-usdhepa-usdlee</guid><category><![CDATA[topgainers]]></category><dc:creator><![CDATA[jktrades]]></dc:creator><pubDate>Wed, 29 Jan 2020 15:54:15 GMT</pubDate><enclosure url="https://images.ecency.com/p/9vWp6aU4y8kwSZ9Gw15LFL3aMdhmgmBBFMpDJregpdP328jDQ2piAwR9RdFWvKKBTAd3deKuZ613Uv4qNyxWocNGfoiUEXeQ2joWgq2s5c2LMe7VLXggG4Uk9Y7dDLA2Nyx4DjCtMnV9D3u7k?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Top Gainers for 1-22-20: $EXPR $GNPX $NTRP $OSS]]></title><description><![CDATA[$EXPR - Express' stock surges after unveiling new 'profitable growth' strategy, to close 100 stores in 2 years: $GNPX - Continuation: Day 2 $NTRP - Neurotrope Provides Corporate Update After Completing]]></description><link>http://direct.ecency.com/topgainers/@jktrades/top-gainers-for-1-22-20-usdexpr-usdgnpx-usdntrp-usdoss</link><guid isPermaLink="true">http://direct.ecency.com/topgainers/@jktrades/top-gainers-for-1-22-20-usdexpr-usdgnpx-usdntrp-usdoss</guid><category><![CDATA[topgainers]]></category><dc:creator><![CDATA[jktrades]]></dc:creator><pubDate>Wed, 22 Jan 2020 15:14:27 GMT</pubDate><enclosure url="https://images.ecency.com/p/9vWp6aU4y8kwSZ9Gw15LFL3aMdhmgmBBFMpDJregpdP329T1iVH4YmwkUaAegvansssgBWsKUNHSB77or4RUUCoNJreYAU78w2ihfqjcoxDbNGzbj1JZyz8S9msee4NGS2ELBsgbrXrNvcDVx?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Top Gainers for 1-21-20: $GNPX $NVAX $VIVE]]></title><description><![CDATA[$GNPX - Genprex Receives U.S. FDA Fast Track Designation for Gene Therapy that Targets Lung Cancer: $NVAX - Novavax shares jump 60% in premarket trading (Heavy Volume): $VIVE - Viveve Initiates Enrollment]]></description><link>http://direct.ecency.com/topgainers/@jktrades/top-gainers-for-1-21-20-usdgnpx-usdnvax-usdvive</link><guid isPermaLink="true">http://direct.ecency.com/topgainers/@jktrades/top-gainers-for-1-21-20-usdgnpx-usdnvax-usdvive</guid><category><![CDATA[topgainers]]></category><dc:creator><![CDATA[jktrades]]></dc:creator><pubDate>Tue, 21 Jan 2020 15:16:06 GMT</pubDate><enclosure url="https://images.ecency.com/p/9vWp6aU4y8kwSZ9Gw15LFL3aMdhmgmBBFMpDJregpdP328QFz4GDxs8WASVM4yhkCyJmMvh9AYRetA5QvUtn5VPfojSGRM1j9xWeVBKECtL4QDhXRiNskcRGfU8ufecrmJCSCdoBdS5zTDJFx?format=match&amp;mode=fit" length="0" type="false"/></item></channel></rss>